ReviewInflammopharmacology2025
Across-the-board review on Omicron SARS-CoV-2 variant.
Rufaida Wasim et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ReviewInflammopharmacology2025
Rufaida Wasim et al.PubMed ↗Publisher ↗
No numbers read from the abstract.